- Investing.com
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
Metrics to compare | ABOT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABOTPeersSector | |
---|---|---|---|---|
P/E Ratio | 46.3x | 28.8x | −0.6x | |
PEG Ratio | 2.81 | 0.69 | 0.00 | |
Price / Book | 17.6x | 6.0x | 2.6x | |
Price / LTM Sales | 9.9x | 4.7x | 3.1x | |
Upside (Analyst Target) | 11.6% | 17.6% | 48.8% | |
Fair Value Upside | Unlock | −6.4% | 7.5% | Unlock |